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Summary
Rhythmic behaviors are a fundamental feature of all
organisms. Pharyngeal pumping, the defecation cy-
cle, and gonadal-sheath-cell contractions are three
well-characterized rhythmic behaviors in the nema-
tode C. elegans. The periodicities of the rhythms range
from subsecond (pharynx) to seconds (gonadal
sheath) to minutes (defecation). However, the molecu-
lar mechanisms underlying these rhythmic behaviors
are not well understood. Here, we show that the C. ele-
gans Rho/Rac-family guanine nucleotide exchange fac-
tor, VAV-1, which is homologous to the mammalian
Vav proto-oncogene, has a crucial role in all three be-
haviors. vav-1 mutants die as larvae because VAV-1
function is required in the pharynx for synchronous
contraction of the musculature. In addition, ovulation
and the defecation cycle are abnormal and arrhyth-
mic. We show that Rho/Rac-family GTPases and the
signaling molecule inositol triphosphate (IP3) act
downstream of VAV-1 signaling and that the VAV-1
pathway modulates rhythmic behaviors by dynamically
regulating the concentration of intracellular Ca2+.
Introduction
Rhythmic activities are ubiquitous biological phenom-
ena and can be observed in cells, tissues, and the be-
havior of most organisms. Biological rhythms regulate
many diverse processes, such as heartbeat, breathing,
locomotion, and gut peristalsis. The molecular ma-
chinery underlying the generation and regulation of
rhythms less than a day in duration—known as ultra-
dian rhythms—are not well understood. To gain a mo-
lecularly based understanding of these biological
rhythms, the use of a genetically tractable organism
has certain advantages. C. elegans hermaphrodites
have three well-characterized rhythmic behaviors.
These include pharyngeal peristalsis that occurs every
1–2 s (Avery and Thomas, 1997), gonadal-sheath-cell
contractions that occur every 7 s (McCarter et al.,
1997), and the defecation motor program that occurs
approximately every 45–50 s (Thomas, 1990). Interestingly,*Correspondence: maricq@biology.utah.edu
5These authors contributed equally to this work.these rhythms are considered nonneurogenic because
they can still be observed following perturbation of ner-
vous-system function. Some of these rhythmic beha-
viors appear to be regulated by changes in intracellular
Ca2+ concentration (Dal Santo et al., 1999; Lee et al.,
1997).
One candidate molecule that is hypothesized to link
activation of receptors at the cell surface to the initia-
tion and control of Ca2+ oscillations is the proto-onco-
gene Vav1, which along with other Vav family members
has a key role in regulating Ca2+ signaling in hematopoi-
etic cells (Bustelo, 2001; Turner and Billadeau, 2002). In-
terestingly, Vav2 and Vav3 are expressed in many other
tissues, including the nervous system and cardiac mus-
cle, where their function is not well understood (Movilla
and Bustelo, 1999; Schuebel et al., 1996). Vav proteins
contain multiple functional domains, including a Src ho-
mology 2 (SH2) domain that links upstream signaling
events to Vav activation and a Dbl homology (DH) do-
main that functions as a guanine nucleotide exchange
factor (GEF) in the activation of downstream Rho/Rac
GTPases (Bustelo, 2001; Turner and Billadeau, 2002).
Following stimulation of the T cell antigen receptor (TCR),
Vav1 is phosphorylated, which turns on GEF function
and leads to the activation of Rho/Rac GTPases. Sub-
sequent activation of phospholipase C (PLC) γ1 gener-
ates inositol triphosphate (IP3), which binds to the IP3
receptor (IP3R), releasing Ca2+ from the endoplasmic
reticulum (ER) and causing an increase in the intracellu-
lar Ca2+ concentration (Bustelo, 2001; Turner and Billa-
deau, 2002). Recently, a triple Vav knockout mouse was
shown to have defects in antigen-stimulated Ca2+ sig-
naling in B and T cells. However, rhythmic behaviors
were not studied in these mice (Fujikawa et al., 2003).
Here we have found that VAV-1, the sole Vav-family
protein in C. elegans, has a critical role in the three
major rhythmic behaviors observed in the nematode.
VAV-1 is expressed in the relevant tissues, and deletion
of the vav-1 gene results in a disruption of pharyngeal
pumping and consequent early larval lethality. Lethality
and pumping are rescued in transgenic vav-1 deletion
mutants by pharynx-specific expression of VAV-1. How-
ever, the transgenic vav-1 mutants display severe de-
fects in fertility and defecation secondary to disrupted
gonadal and intestinal contractile rhythms, respec-
tively. Our results provide new insights into the function
of Vav proteins and demonstrate that VAV-1 has critical
roles in regulating Ca2+ signaling and the generation of
rhythmic behaviors.
Results
vav-1 Encodes a Putative Guanine Nucleotide
Exchange Factor
The C. elegans genome contains a single putative open
reading frame that encodes a polypeptide with greatest
identity to members of the Vav family of GEFs. We iso-
lated a full-length cDNA that is predicted to encode a
1007 amino acid protein, VAV-1 (Figure 1A). VAV-1 has
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120Figure 1. C. elegans vav-1 Encodes a Vav-Family GEF that Is Expressed in Pharynx, Gonad, and Intestine
(A) Amino acid sequence of VAV-1. Conserved tyrosines that are characteristic of Vav proteins (Y183, Y200, and Y217) are indicated by
asterisks. A conserved leucine in the DH domain that is essential for GEF function is indicated by a diamond.
(B) Domain structure of VAV-1. CH, calponin homology; AD, acidic; DH, Dbl homology; PH, plekstrin homology; C1, protein kinase C conserved
region 1; SH2, Src homology 2; SH3, Src homology 3.
(C) Image of a wild-type animal.
(D–H) Transgenic worms expressing in muscle VAV-1::GFP (D); VAV-1::GFP(Y217F) (E); VAV-1(Y3XF) (F); VAV-1(N) (G); VAV-1(N);L260Q (H).
For all animals, anterior is to the right.
(I) VAV-1::GFP expression in the pharynx. GFP is observed in the epidermal cells (EC), pharyngeal muscle (PM), neurons (N), and gland-cell
body (GB) and process (GP).
(J) VAV-1::GFP expression in the spermatheca (s) and the sheath cells of the proximal gonad (pg). Arrowheads indicate sheath cells.
(K) VAV-1::GFP expression in the posterior intestine (int) and rectal epithelial cells (rep). The location of the anus is indicated (a).all of the characteristic domains that are shared by
other members of the vertebrate Vav protein family
(Bustelo, 2001; Turner and Billadeau, 2002). These do-
mains include the calponin homology (CH), acidic (AD),
Dbl homology (DH), pleckstrin homology (PH), protein
kinase C conserved region 1 (C1), Src homology 2
(SH2), and Src homology 3 (SH3) domains (Figure 1B).
The DH domain is the signature feature of GEF proteins
that catalyze the exchange of GDP for GTP on Rho
family GTPases (Bustelo, 2001; Turner and Billadeau,
2002).
Characteristic of Vav proteins are several conserved
tyrosine residues that are important for GEF activity. In
murine Vav1, these include Tyr142, Tyr160, and Tyr174,
which are rapidly phosphorylated by Syk- and Src-
related tyrosine kinases in response to antigen stimula-
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mion of human B and T cells (Bustelo, 2001; Turner and
illadeau, 2002). Of these phosphorylation sites, Tyr174
as a key role in an autoinhibitory regulatory domain
Aghazadeh et al., 2000). Phosphorylation of Tyr174
romotes the displacement of this inhibitory region,
eading to Vav1 GEF activation (Aghazadeh et al., 2000).
he corresponding tyrosine residues are conserved in
. elegans VAV-1 (Tyr183, Tyr200, and Tyr217) (Figure
A), suggesting that VAV-1 might be regulated by a sim-
lar mechanism.
To investigate the function of these conserved tyro-
ines, we used site-directed mutagenesis to generate
217F and Y183F/Y200F/Y217F (Y3XF) mutant variants
f VAV-1. We expressed these VAV-1 variants in trans-
enic worms using the body-wall-muscle-specific pro-
oter, myo-3. We found that expression of the single
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121Y217F and the triple Y3XF mutant construct in the
body-wall muscle led to a dominant hypercontracted
and uncoordinated phenotype (Figures 1E and 1F).
Additionally, we generated an N-terminal deletion of
vav-1, known to result in oncogenic activity of mamma-
lian Vav proteins (Bustelo, 2001; Turner and Billadeau,
2002), in which the CH and AD domains were removed.
Expression of this deletion construct, vav-1(N), in the
body-wall muscle using the myo-3 promoter caused a
phenotype identical to that observed in the Y217F and
the Y3XF mutants (Figure 1G). To test whether this phe-
notype was due to unregulated GEF activity, we modi-
fied the vav-1(N) construct by introducing the L260Q
mutation (vav-1(N);L260Q). The corresponding muta-
tion in vertebrate Vav1 (L213Q) has been shown to sub-
stantially reduce in vivo GEF activity (Crespo et al.,
1996, 1997). As predicted, transgenic worms that ex-
pressed vav-1(N);L260Q had a wild-type phenotype,
indicating that the dominant phenotype observed in
transgenic worms that expressed vav-1(N) was due to
GEF activity (Figure 1H). We also used a biochemical
assay to directly determine whether VAV-1 has GEF activ-
ity. We found that the purified DH/PH domain of VAV-1
was sufficient to promote GDP/GTP exchange on C. ele-
gans Rho/Rac GTPases (Figure S1). These data demon-
strate that C. elegans VAV-1 has GEF activity and that
this activity, like that of the mammalian Vav family mem-
bers, is regulated by tyrosine phosphorylation.
vav-1 Is Expressed in Tissues
that Rhythmically Contract
To determine which cells express VAV-1, we used vav-1
regulatory sequences to drive the expression of full
length VAV-1 fused to the reporter molecule green fluo-
rescent protein (GFP). In transgenic animals that ex-
press VAV-1::GFP, we observed strong GFP fluores-
cence in the pharynx, proximal gonad, spermatheca,
intestine, and rectal epithelia (Figures 1I–1K). In the
pharynx, VAV-1::GFP was observed in most cell types,
including muscle cells, marginal cells, epithelial cells,
neurons, and gland cells (Figure 1I). In the gonad, VAV-
1::GFP was observed in the contractile sheath cells ad-
jacent to the spermatheca (Figure 1J). The expression
of VAV-1::GFP in the intestine was limited to the four
most posterior cells (int8 and int9) and the three rectal
epithelial cells (Figure 1K). Additionally, VAV-1::GFP ex-
pression was observed in the distal gonad, body-wall
muscle, and vulval epithelia (data not shown).
vav-1 Mutants Cannot Feed and Die
Early in Development
To determine the function of VAV-1, we generated a de-
letion mutation that removed approximately 2 kb of ge-
nomic sequence (Figure S2). Homozygous vav-1(ak41)
mutants survive for many days but arrest at the first
(L1) larval stage. Pharyngeal pumping in vav-1 mutants
was grossly abnormal—pharyngeal muscle contrac-
tions were either absent for long periods or asynchro-
nous. We did not observe any obvious defects in pha-
ryngeal morphology that might explain the disrupted
pumping behavior. Likewise, the pharyngeal muscle
displayed a normal radial arrangement of actin, and we
observed no visible defects at the light-microscopiclevel in the organization of pharyngeal adherens junc-
tions (Figure S3). Analysis of two other deletion alleles,
vav-1(ok425) and vav-1(tm402), revealed an L1 lethal
phenotype identical to vav-1(ak41) mutants.
Pharyngeal function and lethality were rescued by
expressing a VAV-1::GFP fusion protein under control
of vav-1 regulatory sequences (see below and Experi-
mental Procedures). To test whether disruption of GEF
activity accounted for the mutant phenotypes, we mod-
ified the rescuing VAV-1::GFP construct by introducing
the L260Q mutation (Crespo et al., 1996, 1997). Trans-
genic vav-1mutants that expressed VAV-1(L260Q)::GFP
at levels similar to rescuing VAV-1::GFP were defective
in pharyngeal pumping, died as L1 larvae, and could
not be distinguished from vav-1 mutants (Figure S4).
These results indicate that GEF activity is required for
the normal function of vav-1.
vav-1 Is Required for Coordinated
Pharyngeal Contraction
Analysis of the pharyngeal defect in vav-1(ak41) mu-
tants using video microscopy and electrical recordings
revealed asynchronous electrical activity of the pharyn-
geal musculature. During normal feeding, the radial
muscles of the pharynx contract simultaneously to
suck food into the opened lumen. A short while later,
this process is reversed and the muscles relax, expel-
ling fluid while retaining food (Albertson and Thomson,
1976). For this process to work efficiently, the muscle-
cell contractions and relaxations must be synchronized
(Avery and Thomas, 1997). Each pharyngeal pumping
action is associated with a characteristic pattern of
muscular electrical activity that can be recorded as an
electropharyngeogram (EPG) (Avery et al., 1995).
Wild-type animals pump approximately 225 times per
minute (Avery and Thomas, 1997). Each pump is asso-
ciated with an excitatory depolarizing wave (E) followed
by a plateau phase (P), often punctuated by brief nega-
tive spikes, and ending with an inhibitory hyperpolariz-
ing wave (R) (Figure 2A). In contrast, EPGs recorded
from vav-1 mutants were highly disorganized (Figure
2B). Examination of mutant EPGs revealed occasional
small-amplitude E waves that continued well into the
plateau phase of each trace (Figure 2B). Accompanying
video microscopy of wild-type (Figure 2D) and vav-1
mutants (Figure 2E) revealed a lack of contractile activ-
ity in the corpus of the pharynx and unsynchronized
contractile activity in the terminal bulb in mutants com-
pared to wild-type. Although some muscle cells of the
terminal bulb did visibly contract, these contractions
were insufficient to open the pharyngeal lumen (Figure
2E, middle). Complete rescue of the EPG and pumping
defects were observed in transgenic vav-1mutants that
expressed VAV-1::GFP under the control of vav-1 regu-
latory sequences (Figures 2C and 2F).
Since Vav proteins have been implicated in Ca2+ sig-
naling in T and B cells (Bustelo, 2001; Turner and Billa-
deau, 2002), we measured pharyngeal Ca2+ transients
in L1 larvae to determine whether the electrical defects
were a result of abnormal Ca2+ signaling. As observed
previously (Kerr et al., 2000), rhythmic increases in in-
tracellular Ca2+ concentration could be detected in
pharyngeal muscle cells of transgenic animals that ex-
Cell
122Figure 2. Pharyngeal Muscle Contractions Are Asynchronous in vav-1 Mutants
(A–C) Representative EPG traces from L1 wild-type (A), vav-1 (B), and a transgenic vav-1 mutant expressing the VAV-1::GFP rescuing clone
(C). Electrical activity corresponding to approximately seven pharyngeal contractions is shown on the left. A time-expanded inset of the EPG
corresponding to a single pharyngeal contraction is shown on the right, with characteristic excitation (E), plateau (P), and relaxation (R) spikes.
(D–F) Video microscopy of pharyngeal muscle contractions in wild-type (D), vav-1 (E), and a transgenic vav-1 mutant expressing VAV-1::GFP
(F). The black arrows identify the terminal bulb, and the white arrows indicate the open (D and F) or closed (E) pharyngeal lumen. The black
arrowhead (E) points to a sole contracting pharyngeal muscle cell in vav-1(ak41).
(G) Schematic representation of the pharynx of C. elegans. Filled circles within the pharynx indicate regions in which Ca2+ transients were
measured. TB indicates terminal bulb of the pharynx.
(H and I) Ca2+ transients observed in a representative wild-type L1 pharynx (H) and vav-1 mutant L1 pharynx (I). The traces in (H) and (I)
correspond to the similarly colored regions of interest shown in (G). Although Ca2+ transients are observed in vav-1 mutants, they are
asynchronous and occur far less frequently.
(J) EPGs from representative wild-type and transgenic rescued vav-1 animals expressing either Pmyo-2::VAV-1 or Ppha-4::VAV-1.pressed cameleon, a ratiometric Ca2+ indicator (Miya-
waki et al., 1997, 1999). The observed Ca2+ spikes al-
ways coincided with pharyngeal muscle contractions
and pumping (Figure 2H). Interestingly, Ca2+ spikes
were synchronous in the musculature of the corpus and
the terminal bulb, indicating coordinated release of
Ca2+ in these muscle groups of the pharynx. In con-
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trast, Ca2+ spikes in vav-1 mutants were infrequent and
rregular (Figure 2I). Moreover, the synchronous Ca2+
pikes that occur within the corpus and the terminal
ulb occur far less frequently in vav-1 mutants (Figure
I). Together, these results suggest that vav-1 is re-
uired for the generation and synchronization of Ca2+
ransients in the musculature of the pharynx.
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ing observed in vav-1 mutants was due to a defective
pharynx or secondary to other defects, we used regula-
tory regions of the pha-4 gene to drive the expression
of VAV-1 in transgenic homozygous vav-1 mutants. The
pha-4 promoter drives expression in almost all pharyn-
geal cells, including muscle cells, marginal cells, epi-
thelial cells, gland cells, and most pharyngeal neurons
(Horner et al., 1998; Kalb et al., 1998). In transgenic
vav-1 mutants that express Ppha-4::VAV-1, pumping
and electrical activity are fully restored (Figure 2J), and
the animals develop into viable adults. Because the
pharyngeal Ca2+ imaging data suggest a specific require-
ment for VAV-1 in pharyngeal muscle, we attempted to
rescue the vav-1 mutant phenotype in transgenic ani-
mals by restricting VAV-1 expression to pharyngeal mus-
cle using the myo-2 promoter (Okkema et al., 1993).
vav-1 mutants that express Pmyo-2::VAV-1 have re-
stored pharyngeal pumping, indicating that the pump-
ing defects were due to altered pharyngeal muscle
function (Figure 2J).
vav-1 Modulates Ovulation Rate via IP3
and the Rho GTPases
We were able to characterize the function of VAV-1 in
tissues other than the pharynx by studying transgenic
vav-1 mutants that expressed the Ppha-4::VAV-1 or
Pmyo-2::VAV-1 transgene. Although these animals sur-
vived to adulthood and appeared to have normal loco-
motion, they had reduced fertility. The average brood
size of transgenic hermaphrodites (vav-1(ak41);Ppha-
4::VAV-1) was 44 ± 7.7 (n = 20), whereas wild-type her-
maphrodites had 284 ± 4.9 progeny (n = 20) (Figure 3A).
Furthermore, we found that vav-1(ak41);Pmyo-2::VAV-1
transgenic mutants had 21 ± 4.1 progeny (n = 40).
Vertebrate Vav1 is required for TCR-dependent intra-
cellular Ca2+ signaling via activation of IP3 receptors,
which are intracellular Ca2+ release channels localized
to the endoplasmic reticulum (Manetz et al., 2001;
Reynolds et al., 2002). Previously, reduction-of-function
mutations in the epidermal growth factor-like (EGF)
gene, lin-3; the EGF-like receptor, let-23 (Clandinin et
al., 1998); and the inositol trisphosphate (IP3) receptor,
itr-1 (Yin et al., 2004), were all found to disrupt ovula-
tion, leading to a reduced brood size. A gain-of-func-
tion mutation (gf) in itr-1 can partially suppress the re-
duced-brood-size defect in let-23 and lin-3 mutants
(Clandinin et al., 1998). Moreover, loss-of-function mu-
tations in the IP3 kinase, lfe-2, and in a type I inositol
polyphosphate 5-phosphatase, ipp-5, can also partially
suppress the brood-size defect in let-23 and lin-3 mu-
tants (Bui and Sternberg, 2002; Clandinin et al., 1998).
To investigate whether vav-1 acts in an IP3 signaling
pathway, we generated double mutants or used RNA
interference (RNAi) to knock down gene function. The
brood size of itr-1(gf);vav-1(ak41);Pmyo-2::VAV-1 and
itr-1(gf);vav-1(ak41);Ppha-4::VAV-1 double mutants was
significantly larger than vav-1(ak41);Pmyo-2::VAV-1 and
vav-1(ak41);Ppha-4::VAV-1 mutants alone, respectively
(Figure 3A). Additionally, lfe-2(RNAi) or ipp-5(RNAi) to
vav-1(ak41);Pmyo-2::VAV-1 mutants significantly sup-
pressed the brood defect (Figure 3A). Further support
for the hypothesis that vav-1 functions to regulate IP3comes from double mutants containing a reduction-of-
function mutation in the IP3 receptor, itr-1(rf), and vav-
1(ak41);Ppha-4::vav-1 mutants. These mutants were
almost completely sterile, displaying phenotypic en-
hancement over either single mutation (Figure 3A). To
investigate the possibility of vav-1 acting in the EGF
signaling pathway during ovulation, we made double
mutants with vav-1;Ppha-4::VAV-1 and a gain-of-func-
tion mutation in the EGF receptor, let-23(gf). Unlike
itr-1(gf), let-23(gf) did not significantly improve the
brood-size defect observed in vav-1(ak41);Ppha-4::
VAV-1 mutants (Figure 3A). This suggests that the let-
23/EGFR acts upstream of vav-1 to promote ovulation.
Since vav-1 is also expressed in the vulval epithelia,
it is possible that an egg-laying defect may contribute
to the smaller brood size observed in vav-1(ak41);Ppha-
4::VAV-1 mutants. However, mutants that are defective
in egg laying typically are bloated with retained eggs.
In contrast, vav-1 mutants did not appear bloated by
visual inspection. Eggs that are retained due to a laying
defect will have progressed further in development.
Therefore, a microscopic examination of recently laid
eggs provides a more sensitive assay for defects in egg
laying. Eggs from wild-type and vav-1(ak41);Ppha-4::
VAV-1 mutants were indistinguishable, indicating that
vav-1 mutants do not have an egg-laying defect (Figure
3B). In contrast, eggs laid by egl-19(n582) mutants (de-
fective in contraction of the vulval muscles) (Lee et al.,
1997; Trent et al., 1983) were at a much later develop-
mental stage.
Low brood size can be caused by other factors, such
as impaired sperm production or mobility or defective
ovulation. VAV-1 is expressed in the gonadal-sheath
cells and spermatheca, suggesting that VAV-1 may also
be required for ovulation or sperm function. However,
mating wild-type males with vav-1 mutant hermaphro-
dites did not restore the brood size to normal levels
(Figure 3C), indicating that the reduced fertility of
vav-1 mutants was more likely due to an ovulation de-
fect. To test this hypothesis, we video-recorded sheath-
cell contractions and ovulations from immobilized
worms. We found that the basal sheath-cell contrac-
tion rate was slower in mutants. In wild-type animals,
the average basal contraction rate is approximately 8
contractions/min, whereas in vav-1;Ppha-4::VAV-1 and
vav-1;Pmyo-2::VAV-1 mutants the contraction rate is
approximately 5 and 2 contractions/min, respectively
(Figure 3D).
We next examined the cellular events associated
with ovulation. In wild-type animals, oocytes align on
the proximal-distal axis of the gonad and undergo a
series of changes during ovulation that occur in an as-
sembly-line manner (McCarter et al., 1999). These con-
sist of oocyte maturation, which includes nuclear-enve-
lope breakdown and cortical rearrangement; dilation of
the spermatheca; and sheath-cell contractions, which
pull the dilated spermatheca over the mature oocyte,
allowing entry into the spermatheca and fertilization
(Figure 4A). In both vav-1(ak41);Ppha-4::VAV-1 and vav-
1(ak41);Pmyo-2::VAV-1 mutants, the oocytes developed
normally until they reached the spermatheca. However,
at this point, several defects were observed, such as
ovulation of immature oocytes (Figure 4B), premature
spermatheca constriction (Figure 4C), and overexten-
Cell
124Figure 3. vav-1 Mutants Have Reduced Fertility and Irregular Gonadal-Sheath-Cell Contractions
(A) Brood size. Statistically different from wild-type (*p < 0.0001), vav-1;Ppha-4::VAV-1 (**p < 0.0001), or vav-1;Pmyo-2::VAV-1 (***p < 0.0001).
(B) Egg-laying behavior. The stage of freshly laid eggs was scored and classified as 1–8 cell stage, 9 cell–comma stage, and postcomma.
More than 100 eggs were scored for each genotype.
(C) Brood size following mating with wild-type (wt) males. Statistically different from wild-type (*p < 0.0001).
(D) Basal sheath-cell contraction rate. vav-1;Ppha-4::VAV-1 mutants are statistically different from both wild-type (*p < 0.0001) and vav-1;
Pmyo-2::VAV-1 mutants (*p < 0.0005). Error bars indicate standard error of the mean (SEM).sion of the spermatheca past the proximal oocyte. (Fig-
ure 4D). These defects were associated with constric-
tion and damage of the oocyte. Additionally, we occa-
sionally observed that the oocytes did not enter the
spermatheca in vav-1(ak41);Pmyo-2::VAV-1 mutants and
arrested with an endomitotic phenotype (Figure 4E). In
sum, our data indicate that vav-1 is required for the nor-
mal coordination of sheath-cell contractions, sperma-
thecal dilation, and oocyte maturation and likely acts
through the IP3R.
Since we found that VAV-1 acts as a Rho/Rac-family
guanine nucleotide exchange factor (Figure S1), we inves-
tigated whether disrupting any of the Rho/Rac GTPases
of C. elegans causes defects in ovulation. C. elegans con-
tains three genes encoding Rac GTPases, ced-10,mig-2,
and rac-2 (Chen et al., 1993a; Lundquist et al., 2001);
one Rho GTPase, rho-1; and one Cdc42 GTPase, cdc-
42 (Chen et al., 1993b; Chen and Lim, 1994). Analysis
of RNAi knockdown of candidate Rho/Rac GTPase-
encoding genes or analysis of known mutants revealed
that only rho-1(RNAi) had a phenotype similar to vav-
1(ak41);Pmyo-2::VAV-1 mutants (Figure 4F). Double-
mutant analysis of cdc-42(RNAi);mig-2 and cdc-
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l42(RNAi);ced-10 revealed severe migration defects ofhe gonadal distal-tip cells, resulting in abnormal gonad
evelopment. ced-10;mig-2 mutants also had gonadal
igration defects as well as oocyte development de-
ects. These findings prevented analysis of ovulation
n these double mutants. These data indicate that
av-1 is involved in regulating ovulation by modulating
P3 signaling and that this signaling pathway may in-
olve the small GTPase rho-1.
av-1 Function Is Required for a Normal
efecation Cycle
efecation in C. elegans is composed of three sequen-
ial motor steps: posterior body-wall-muscle contraction
pBoc), anterior body-wall-muscle contraction (aBoc),
nd enteric-muscle contraction (Emc) leading to expul-
ion (Avery and Thomas, 1997). This motor program is
epeated approximately every 45–50 s. In vav-1;Ppha-
::VAV-1 mutants, the three sequential motor steps oc-
urred normally, i.e., once initiated, the timing and order
f the three steps was normal. However, the cycle
eriod (defined by the interval between successive
Bocs) was irregular, and the mean cycle time was
engthened to approximately 85 s (Figures 5A and 5C).
Because the pha-4 promoter is weakly expressed in
VAV-1 Regulates Rhythmic Behaviors in C. elegans
125Figure 4. Ovulation Is Defective in vav-1 Mu-
tants
(A–D) Ovulation events in wild-type (A) and
transgenic vav-1;Ppha-4::VAV-1 animals (B–D).
Numbers indicate the time (min) prior to ovu-
lation, with ovulation occurring at time 0. Oo,
oocyte; Sp, spermatheca; Nu, nucleus. (A
and B) The nucleus is clearly discernable
(arrowhead) in the left panel. (A) Coincident
with nuclear-envelope breakdown (black ar-
rowhead; middle panel), the oocyte enters
the spermatheca. (B) Nuclear envelope break-
down does not occur in the vav-1mutant (ar-
rowhead; middle panel). The arrows indicate
the spermatheca engulfing the oocyte. The
right panels show an oocyte completely en-
gulfed by the spermatheca. Note the pres-
ence of a discernable nucleus in the mutant
(B) compared to wild-type (A). (C) An oocyte
in a vav-1 mutant that is severed in half by
the spermatheca (right). In this example, the
nuclear envelope has broken down (arrow-
head). (D) The spermatheca of a vav-1 mu-
tant overextends and pinches (arrows) the
second oocyte.
(E) In transgenic vav-1;Pmyo-2::VAV-1 mu-
tants, many oocytes fail to enter the sperma-
theca, resulting in the accumulation of en-
domitotic oocytes (arrowheads).
(F) In a rho-1(RNAi) worm, oocytes fail to en-
ter the spermatheca and become endomi-
totic (black arrowhead); a more distal oocyte
undergoes maturation precociously (white
arrowhead). In all pictures, the vulva is to the
right. Scale bar = 25 m.intestinal cells (Kalb et al., 1998), we also examined
defecation in vav-1(ak41);Pmyo-2::VAV-1 mutants. While
these animals still defecate, the average cycle duration
was approximately 195 s, the cycle was highly variable
and irregular (Figures 5A–5C), and frequently the expul-
sion step was skipped.
We used mosaic analysis to identify the cells in which
VAV-1 function is required for the periodicity of defeca-
tion (Figure 6). To do this, we characterized defecation
in transgenic vav-1 mutants expressing two linked
transgenes: the vav-1 rescuing genomic clone and a
Psur-5::NLS::GFP clone that is expressed in the nuclei
of all somatic cells and is a well-established tool for
mosaic analysis (Yochem et al., 1998). We found that,
in all cases, young adult mosaic animals lacking the
transgenes in the E lineage, which gives rise to the in-
testine, were defecation defective (Figure 6). Further-
more, in cases where the transgenes were present in
the E lineage, the defecation cycle was normal.
vav-1 Controls the Duration of the Defecation Cycle
via IP3 and the Rho/Rac GTPases
The IP3 receptor has also been implicated in the control
of the defecation cycle. Loss-of-function mutations in
itr-1 result in the slowing or absence of the pBoc-pBocdefecation cycle (Dal Santo et al., 1999). To investigate
whether the gain-of-function itr-1(gf) mutation could
suppress the impaired defecation in vav-1 mutants, we
examined the defecation cycle in itr-1(gf);vav-1(ak41);
Pmyo-2::VAV-1 mutants. Consistently, the defecation-
cycle rhythm was improved in itr-1(gf);vav-1(ak41);
Pmyo-2::VAV-1 double mutants compared to vav-
1(ak41);Pmyo-2::VAV-1 single mutants. (Figure 5A). We
also found partial suppression of the defecation-cycle-
rhythm defect in vav-1(ak41);Pmyo-2::VAV-1 mutants
treated with lfe-2(RNAi) (Figure 5A). In contrast, we did
not observe suppression in mutants treated with ipp-
5(RNAi) (Figure 5A). Additionally, we examined double
mutants containing a reduction-of-function allele of
itr-1 and vav-1(ak41);Ppha-4::VAV-1 and found that
the defecation cycle was significantly extended in the
double mutant as compared to the single mutants (Fig-
ure 5A). These data suggest that vav-1 functions via IP3
signaling to regulate the defecation cycle.
Does VAV-1 signal through the C. elegans Rho/Rac
GTPases to control the timing of the defecation cycle?
To determine whether these genes are involved, we ex-
amined the defecation cycle in known mutants or used
RNAi knockdown of specific Rho/Rac GTPases. RNAi
knockdown of cdc-42, ced-10, mig-2, rac-2, and rho-1
Cell
126Figure 5. The Timing of the Defecation Cycle Is Altered in vav-1 Mutants
(A) Average time interval between consecutive pBocs. Statistically different from wild-type (*p % 0.0001), vav-1;Pmyo-2::VAV-1 (**p % 0.02),
vav-1;Ppha-4::VAV-1, or itr-1(rf)(***p % 0.0001).
(B) The duration of ten defecation cycles in representative wild-type, vav-1;Pmyo-2::VAV-1, and vav-1 rescued animals.
(C) Coefficient of variance. Statistically different from wild-type (*p % 0.02). Error bars indicate SEM.individually did not reveal any significant defects in def-
ecation timing (Figure 5A and data not shown). Addi-
tionally, analysis of ced-10 and mig-2 single mutants
did not reveal any significant defecation timing defects
(Figure 5A). Given that there are five genes encoding
Rho/Rac GTPases in C. elegans, it is possible that there
is genetic redundancy. Consistent with this, we found
that RNAi knockdown of rho-1 in the mutant back-
ground of ced-10 or mig-2 caused an extended and
arrhythmic defecation cycle (Figures 5A and 5C). More-
over, we found that ced-10;mig-2 double mutants had
significantly lengthened and arrhythmic defecation cy-
cles (Figures 5A and 5C). We could not extend this
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wnalysis because rho-1 RNAi knockdown in the ced-
0;mig-2 double mutant was larval lethal. In contrast,
e observed no defecation defects in cdc-42(RNAi);
ig-2 and cdc-42(RNAi);ced-10 mutants. These data
emonstrate that ced-10, mig-2, and rho-1 have a re-
undant function in controlling the periodicity of the
efecation cycle.
To further dissect the role of vav-1 and the Rho/Rac
TPases, we engineered a constitutively active GEF
utation (Y3XF) (see above) in VAV-1 that was ex-
ressed solely in the intestine by the ges-1 promoter,
ges-1::vav-1(gf). Expression of Pges-1::vav-1(gf) in
ild-type animals resulted in abnormal defecation-
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127Figure 6. VAV-1 Expression in the Intestine Restores the Defecation Cycle in vav-1 Mutants
(A) Cell lineage of C. elegans, indicating the tissue that arises from each lineage. Exc is the excretory cell, and Hyp7 denotes the cells that
make up the epidermis.
(B) Mosaic animals are represented by a cell lineage. The number above the lineage indicates the number of animals in each class. The open
circle represents where in the embryonic lineage the extrachromosomal array was lost in non-defecation-defective (non-Dec) mosaic animals.
The closed circle represents where in the embryonic lineage the array was lost in defecation-defective (Dec) mosaic animals.cycle timing. The defecation cycle of these animals was
arrhythmic and extended compared to wild-type ani-
mals that did not express the Pges-1::vav-1(gf) trans-
gene (Figure 5A). To determine whether the Rho/RacGTPases act downstream of vav-1, we carried out RNAi
knockdown experiments of the Rho/Rac GTPases in
animals expressing the Pges-1::vav-1(gf) transgene. We
found that RNAi knockdown of ced-10, mig-2, and
Cell
128rho-1 could suppress the defecation timing defect ob-
served in Pges-1::vav-1(gf)-expressing animals (Figure
5A). In contrast, cdc-42(RNAi) did not significantly sup-
press the defecation timing defects of Pges-1::vav-
1(gf)-expressing animals (Figure 5A). These data indi-
cate that ced-10, mig-2, and rho-1 act downstream of
vav-1 to regulate defecation-cycle timing.
VAV-1 may function in a signaling pathway to activate
phosphatidylinositol 4-phosphate 5 kinase (PIP5K) to
generate phosphatidylinositol(4,5)biphosphate (PIP2),
the substrate for IP3 production. To test this hypothesis,
we knocked down the function of ppk-1/PIP5K by RNAi
and found an almost complete absence of the defeca-
tion cycle (no pBoc observed in > 600 s of observation),
indicating a critical role for PIP5K in the control of defe-
cation. To test whether VAV-1 functions upstream of
PIP5K, we also knocked-down ppk-1/PIP5K in trans-
genic worms that expressed vav-1(gf). The phenotype
of the worms following RNAi was similar to ppk-1 alone
(no pBoc observed in > 600 s of observation), indicating
that ppk-1/PIP5K acts downstream of vav-1. These re-
sults indicate that IP3 production is dependent on the
activation of VAV-1
Intracellular Ca2+ Oscillations Are Abnormal
in vav-1 Mutants
Our genetic evidence indicates that vav-1 is required
for IP3 generation. Thus, in vav-1 mutants, the release
of Ca2+ from intracellular stores may be impaired, lead-
ing to impaired rhythmic contractility. Since Ca2+ sig-
naling in the pharynx was abnormal in vav-1 mutants,
we also investigated Ca2+ signaling in the intestines. To
analyze intracellular Ca2+ oscillations, we loaded iso-
lated intestines with the indicator Fluo-4 and imaged
fluorescence intensity (see Experimental Procedures).
In wild-type animals, Ca2+ oscillations were observed
at very regular intervals, similar to the timing of the def-
ecation cycle, and were highly reproducible (Figures
7A, 7D, and 7E). In contrast, vav-1;Pmyo-2::VAV-1 mu-
tants had an arrhythmic and lengthened Ca2+ oscilla-
tion frequency similar to the defective defecation beha-
vior observed in these animals (Figures 7B, 7D, and 7E).
Additionally, we found that the lengthened Ca2+ oscilla-
tion frequency observed in vav-1;Pmyo-2::VAV-1 mu-
tants was suppressed by a gain-of-function mutation in
itr-1; however, the frequency of Ca2+ signaling remains
arrhythmic (Figures 7D and 7E). Consistent with the
Rho/Rac GTPases acting downstream of VAV-1, ced-
10;mig-2 mutants showed a phenotype similar to vav-1;
Pmyo-2::VAV-1. The double mutant had arrhythmic and
lengthened defecation cycles (Figures 7C–7E). These
results suggest that VAV-1 regulates Ca2+ oscillations
via Rho GTPases within the intestines to control the
rhythmic behavior of the defecation cycle.
Discussion
We have found that vav-1 is required for three different
rhythmic behaviors: the synchronous pumping of the
pharynx, the coordinated contractions of sheath cells
and dilation of the spermatheca, and the periodicity of
the defecation cycle. We have also shown that, in the
intestines, VAV-1 function is dependent on members
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bof the Rho/Rac family of GTPases and IP3 signaling.hese data suggest that VAV-1 is part of a signaling
athway used by a variety of tissues to control the re-
ease of intracellular Ca2+ and generate rhythmic activ-
ty. Consistent with this model, we observed abnormal
a2+ transients in pharyngeal muscle and the intestines
f vav-1 mutants and Rho/Rac double mutants.
AV-1 Is Required for Synchronous
ontraction of the Pharynx
n vav-1 mutants, pharyngeal contraction is weak and
synchronous, leading to ineffectual pharyngeal pump-
ng and consequent early larval death. We have shown
hat VAV-1 expression in pharyngeal muscle is sufficient
o rescue the pharyngeal pumping defects of vav-1mu-
ants. How then might VAV-1 affect pharyngeal muscle
unction? One could imagine that vav-1 mutants have
efects in muscle depolarization, excitation-contrac-
ion coupling, myosin-dependent force generation, or
ap-junction-mediated communication between pha-
yngeal muscle cells. The asynchrony of terminal-bulb-
uscle cell contraction and the abnormal, long-dura-
ion EPG traces from vav-1 mutants suggest that the
ellular defect may originate from disrupted electrical
onduction, defective Ca2+ release from intracellular
tores, or the diffusion of Ca2+ between neighboring
uscle cells.
We found abnormal Ca2+ transients in the pharyngeal
usculature of vav-1 mutants. Interestingly, a null mu-
ation in the gene encoding sarcoendoplasmic reticu-
um Ca2+ transport ATPase (sca-1), which is required
or restoring Ca2+ stores, results in an L1 lethal pheno-
ype that is very reminiscent of vav-1 mutants (Zwaal et
l., 2001). Furthermore, mutations in Ca2+ channels that
re expressed in the pharynx result in abnormal pharyn-
eal contraction. These include the egl-19 L type volt-
ge-gated Ca2+ channel α1 subunit (Lee et al., 1997),
he unc-68 ryanodine receptor (Maryon et al., 1996; Sa-
ube et al., 1993), and the itr-1 IP3 receptor (Walker et
l., 2002). In addition, the pharyngeal muscle cells are
onnected to one another by gap junctions formed by
nnexins (Phelan and Starich, 2001; Starich et al., 2001),
nd mutations in these proteins disrupt coordinated
ontraction (Li et al., 2003; Starich et al., 1996). There-
ore, VAV-1 may also regulate the activity of the innexin
roteins, thus preventing Ca2+ diffusion to other muscle
ells. However, altered Ca2+ levels only partly explain
he abnormal EPG, which measures ion flux across the
ell membrane. The altered EPG suggests that the ac-
ivity of plasma-membrane ion channels is altered,
ither directly via VAV-1 signaling pathways or indirectly
ia the action of Ca2+ ions.
heath-Cell Contractions and Ovulation
re Disrupted in vav-1 Mutants
he synchronized contractions of the sheath cells and
ilation of the spermatheca are dependent on EGF sig-
aling (Bui and Sternberg, 2002; Clandinin et al., 1998;
cCarter et al., 1999; Yin et al., 2004). Reduction-of-
unction mutations in either the EGF-like protein, lin-3,
r the EGF-like receptor, let-23, cause sterility because
he spermatheca does not dilate. Similar to lin-3 and
et-23 mutants, vav-1 mutants have a greatly reduced
rood size, and this defect is suppressed by a gain-of-function mutation in the IP3 receptor, itr-1, and func-
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129Figure 7. Intestinal Ca2+ Transients Are Altered in vav-1 Mutants
(A–C) Intestinal Ca2+ transients observed in a representative wild-type (A), vav-1 mutant (B), and ced-10; mig-2 double mutant (C).
(D) Quantification of time between consecutive Ca2+ oscillations. Statistically different from wild-type (*p % 0.005) and vav-1(ak41);Pmyo-
2::VAV-1 (**p % 0.0001).
(E) Coefficient of variance. Statistically different from wild-type (*p % 0.01).
(F) Model of vav-1 signaling during fertilization and defecation timing. Abbreviations are as indicated in the text except the following: RTK,
receptor tyrosine kinase; CTK, cytoplasmic tyrosine kinase; IPP, type I inositol 5-phosphatase. Error bars indicate SEM.tional knockdown of the IP3 kinase, lfe-2, and a type
I inositol 5-phosphatase, ipp-5. Moreover, we have
found a phenotypic enhancement when a weak loss-
of-function mutation of the IP3R, itr-1(rf), is introduced
into the vav-1;Ppha-4::VAV-1 background (weak vav-1
background). In addition, a gain-of-function mutation
in let-23/EGFR could not bypass the brood-size defect
observed in vav-1 mutants. These data suggest that
vav-1 acts upstream of IP3 signaling and downstream
of the EGFR. Consistent with the idea of vav-1 acting
downstream of EGF signaling, mammalian Vav family
members have also been implicated in EGF signaling
(Bustelo and Barbacid, 1992; Margolis et al., 1992;
Movilla and Bustelo, 1999; Pandey et al., 2000), and, in
Drosophila, DroVav has been found to be highly phos-
phorylated after EGF receptor activation (Hornstein et
al., 2003).
How might vav-1 function in the C. elegans EGF/IP3
signaling pathway? As suggested by the mammalian
and Drosophila studies, LIN-3/EGF stimulation maylead to rapid phosphorylation and activation of VAV-1.
In mammalian cells, phosphorylated VAV-1 activates
PLCγ to generate IP3 (Manetz et al., 2001; Reynolds et
al., 2002). Consistent with PLCγ having a role in ovula-
tion, RNAi inactivation of the C. elegans PLCγ (plc-3)
results in a severe defect in ovulation (Yin et al., 2004).
Alternatively, VAV-1 may activate PIP5K, which gener-
ates PIP2, the substrate of PLCγ. Consistent with this
model, studies of signaling in B lymphocytes have sug-
gested that Vav1 activates PIP5K (O’Rourke et al.,
1998). C. elegans has three genes encoding PIP5K-like
proteins, ppk-1, ppk-2, and ppk-3, and a C. elegans ge-
nome-wide RNAi screen has revealed a sterility defect
in ppk-1(RNAi)-treated animals (Kamath et al., 2003;
Simmer et al., 2003).
The Defecation Cycle in vav-1 Mutants Is Irregular
The defecation cycle in C. elegans is highly regular, so
much so that it has been termed a cellular clock (Dal
Santo et al., 1999; Iwasaki and Thomas, 1997). In con-
Cell
130trast, the cycle in vav-1 mutants is arrhythmic and no
longer clock-like, suggesting that VAV-1 either is part of
a clock or is a critical modulator of a complex rhythm.
In mammalian cells, Vav is known to be regulated by
external signals acting through membrane receptors
(Bustelo, 2001; Turner and Billadeau, 2002). By analogy,
we expect that receptor-mediated signaling regulates
rhythmic activity via activation of VAV-1. In support of
this hypothesis, the defecation cycle is dependent on
the presence of food (Iwasaki and Thomas, 1997), indi-
cating the possible involvement of other signaling path-
ways. In addition, cycle duration approximately doubles
when the concentration of food is lowered (Liu and
Thomas, 1994) and decreases in duration with temper-
ature shifts from 20°C to 25°C (Branicky et al., 2001),
again suggesting that sensory input regulates the defe-
cation rhythm.
Previous experiments demonstrated that IP3 receptor
function in the intestine was required for the defecation
cycle and that a Ca2+ spike, which occurred approxi-
mately every 50 s in the intestine, was absent in itr-1
IP3 receptor null mutants or slowed in the hypomorphic
mutant (Dal Santo et al., 1999). We found that a gain-
of-function mutation in itr-1, which leads to a 2-fold in-
crease in IP3 affinity (Walker et al., 2002), was capable
of partially suppressing the defecation defects ob-
served in vav-1 mutants. Furthermore, we found that
lfe-2(RNAi) could also partially suppress the defecation
defect observed in vav-1 mutants. In contrast, ipp-
5(RNAi) did not significantly suppress the defecation
defect. However, ipp-5 is only expressed in the sper-
matheca and the proximal gonad (Bui and Sternberg,
2002), whereas itr-1 and lfe-2 are both reported to be
expressed in the intestine as well as the gonad/sper-
matheca (Baylis et al., 1999; Dal Santo et al., 1999;
Clandinin et al., 1998). As was observed for gonad
function, we found a synthetic enhancement of the du-
ration of the defecation cycle when a weak loss-of-
function mutation of the IP3R, itr-1, was introduced into
the vav-1;Ppha-4::vav-1 background, providing further
evidence that vav-1 functions via IP3 to regulate the
rhythm of the defecation cycle. Additionally, we found
that RNAi of Rho/Rac GTPases causes abnormal defe-
cation cycles in wild-type worms and could partially
suppress the defecation defects caused by the overex-
pression of a vav-1(gf) transgene. We also found that
RNAi of ppk-1/PIP5K causes a defective defecation cy-
cle. Consistent with C. elegans Rac and Rho proteins
acting to modulate IP3 levels, both mammalian Rac1
and RhoA have been implicated in the activation of
PIP5K (O’Rourke et al., 1998; Saci and Carpenter, 2005).
Together, our data suggest a model where VAV-1 func-
tions in the intestine via the Rho/Rac GTPases to mod-
ulate IP3 signaling and the rhythm of the defecation cy-
cle (Figure 7F).
In summary, our data indicate that VAV-1 has an evo-
lutionarily conserved role in Ca2+ signaling and modu-
lates three major rhythmic behaviors found in C. ele-
gans. These rhythms are considered nonneurogenic in
that they do not appear to be directly driven by ner-
vous-system input and thus may be more analogous
to the intrinsic rhythms found in tissues such as the
vertebrate heart, which are modulated by external sig-
nals. In the absence of VAV-1, Ca2+ signaling and
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Cumping, ovulation, and defecation behaviors are still
resent, but the cycles are longer and arrhythmic. Be-
ause VAV-1 is required for three different rhythmic be-
aviors in C. elegans, VAV-1 may act as a global regula-
or of biological rhythms through its modulation of Ca2+
scillations. Since biological rhythms are a critical fea-
ure of all organisms, it is possible that VAV-1-like pro-
eins have similar roles in other biological systems.
xperimental Procedures
eneral Methods and Strains
trains were maintained using standard procedures. Wild-type re-
ers to the Bristol N2 strain, and the mutant alleles are listed in the
upplemental Experimental Procedures. All experiments, unless
therwise noted, were carried out at 24°C. Brood sizes were estab-
ished by placing single L4 hermaphrodites of each genotype on
ndividual plates with the E. coli strain OP50. Animals were transfer-
ed to fresh plates containing OP50 every 12 hr for 4 days. The
esulting F1 progeny were counted shortly after the transfer of her-
aphrodites. For each genotype, a minimum of 20 animals were
cored. Defecation-cycle length in young adult animals was carried
ut as described (Dal Santo et al., 1999). Mosaic analysis was car-
ied out as described (Yochem and Herman, 2003). RNAi was car-
ied out as described (Kamath et al., 2003; Simmer et al., 2003;
immons et al., 2001), except for the analysis of rho-1 and cdc-42.
NAi to cdc-42 and rho-1 was conducted on L1 larvae, and young
dults were examined. Statistical analysis was carried out by
NOVA and unpaired t tests using StatView. Coefficient of variance
as calculated by standard deviation/mean × 100.
a2+ Imaging
haryngeal cameleon Ca2+ imaging was carried out on a Zeiss
xioplan 2 microscope equipped with a Roper Cascade 512B CCD
amera, a Dual View beam splitter (Optical Instruments), and a
ambda DG4 light source (Sutter). For pharyngeal recordings, L1
arvae were immobilized in M9 containing 1 mM levamisole and 10
M serotonin. Images were collected at w20 Hz (5 ms exposure
ime) using a Zeiss 100× 1.4 N.A. Plan-Apochromat. For Fluo-4 (Mo-
ecular Probes) loading, animals were dissected by decapitation,
nd the intestine was allowed to partially exit the body cavity. Intes-
ines were loaded with 1–5 M Fluo-4 for 10 min and then thor-
ughly washed with buffer (described in Supplemental Experimen-
al Procedures). Images were collected every 1–5 s (100–200 ms
xposure time) using a Zeiss 40× 1.3 N.A. Plan Neofluar objective
ens. All fluorescence images were acquired and analyzed using
etaFluor 6.2r2 (Universal Imaging).
upplemental Data
upplemental Data include Supplemental Experimental Proce-
ures, Supplemental References, and four figures and can be found
ith this article online at http://www.cell.com/cgi/content/full/123/1/
19/DC1/.
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